GYRE
Gyre Therapeutics, Inc. Common Stock
$6.84
0.44%
+0.03
Notify me if price changes either direction
Buy GYRE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
656.0M
Enterprise value
603.9M
Trailing PE
339.00003
Forward PE
113.00001
Enterprise to EBITDA
43.1
Enterprise to revenue
5.18
Price to book MRQ
5.839793
Price to sales TTM
5.60211
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
116.6M
EBITDA
11.3M
Diluted EPS TTM
0.02
Total Cash (MRQ)
52.4M
Current ratio (MRQ)
5.598
Operating Cash Flow (TTM)
1.0M
GYRE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
